Conditions: Secondary Hyperparathyroidism Chronic Renal Insufficiency
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 54
Healthy volunteers: no

Brief summary:
This study will assess an investigational medication for patients with chronic renal insufficiency (pre-dialysis) who have secondary hyperparathyroidism.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: cinacalcet (AMG 073)
Intervention descriptions: intervention 1: Initially receive 1 tablet of study medication (cinacalcet or placebo) once daily. Possible sequential dose titrations are 30, 60, 90, 120, 180mg cinacalcet or placebo) daily. The titration phase was 12 weeks and the efficacy assessment phase was 6 weeks.

Protocol document: